Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group (Q47244827)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q6087190)
(P304) 49-61
(P433) 1
(P478) 8
(P577) Saturday, January 1, 2000
(P921) (Q12174)
(Q11068)
(P1433) (Q15763232)
(P1476) "Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group" (language: en)
(P2093) Sjöström L
Noack R
Meinders AE
Noseda G
(P2860) (Q22250911)
(Q28264906)
(Q36768288)
(Q36904662)
(Q40791579)
(Q47284487)
(Q53597409)
(Q39419985)
(Q53407808)
(Q36904283)
(Q34062086)
(Q64133342)
(Q93899811)
(Q35529947)
(Q36731331)
(Q72066041)
(Q74648679)
(Q72797825)
(Q71622341)
(Q71643245)
other details
description scientific article

External Links